Stay updated with breaking news from Youry Kim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Although antiretroviral therapies are the standard of care treatment for those with HIV, the drugs cannot target latent infections; however, venetoclax, a blood cancer treatment, shows promise.
An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfection, which could lead to a future cure for the disease.
The drug in question is called venetoclax, and it can be repurposed and used to address HIV infection, as per the researchers behind the study.
Although promising, questions remain about whether this could be a ‘cure’, or just a way to limit the number of these cells in the body.
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease. Hidden HIV cells, known as latent infection, are responsible for the virus permanently remaining in the